Jian-Wei Xu1, Rogan Lee2, Xiao-Hong Li3, Hui Liu4. 1. Yunnan Institute of Parasitic Diseases, Yunnan Provincial Centre of Malaria Research, Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Yunnan Institute of Parasitic Diseases Innovative Team of Key Techniques for Vector Borne Disease Control and Prevention (Developing), Training Base of International Scientific Exchange and Education in Tropical Diseases for South and Southeast Asia, Puer, 665000, China. 2. The Centre for Infectious Diseases and Microbiology, New South Wales Health Pathology, and Westmead Clinical School, The University of Sydney, Westmead Hospital, Sydney, NSW, 214, Australia. 3. National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, 200025, China. 4. Yunnan Institute of Parasitic Diseases, Yunnan Provincial Centre of Malaria Research, Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Yunnan Institute of Parasitic Diseases Innovative Team of Key Techniques for Vector Borne Disease Control and Prevention (Developing), Training Base of International Scientific Exchange and Education in Tropical Diseases for South and Southeast Asia, Puer, 665000, China. liubible@126.com.
Abstract
BACKGROUND: Globally, malaria is still a major public health challenge. Drug-based treatment is the primary intervention in malaria control and elimination. However, optimal use of mass or targeted treatments remains unclear. A variety of radical, preventive and presumptive treatment regimens have been administrated in China and a systematic review was conducted to evaluate effectiveness, and discuss experiences, limitations, and lessons learnt in relation to the use of these regimens. METHODS: The search for information includes both paper documents, such as books, malaria control annals and guidelines for malaria prevention and treatment, as well as three computer-based databases in Chinese (CNKI, WanFangdata and Xueshu.baidu) and two databases in English (PubMed and Google Scholar), to identify original articles and reports associated with drug administration for malaria in China. RESULTS: Starting from hyperendemicity to elimination of malaria in China, a large number of radical, preventive and presumptive treatment regimens had been tried. Those effective regimens were scaled up for malaria control and elimination programmes in China. Between 1949 and 1959, presumptive treatment with available anti-malarial drugs was given to people with enlarged spleens and those who had symptoms suggestive of malaria within the last 6 months. Between 1960 and 1999, mass drug administration (MDA) was given for preventive and radical treatment. Between 2000 and 2009, the approach was more targeted, and drugs were administed only to prevent malaria infection in those at high risk of exposure and those who needed radical treatment for suspected malaria. Presumptive therapy was only given to febrile patients. From 2010, the malaria programme changed into elimination phase, radical treatment changed to target individuals with confirmed either Plasmodium vivax or Plasmodium ovale within the last year. Preventive treatment was given to those who will travel to other endemic countries. Presumptive treatment was normally not given during this elimination phase. All cases of suspected were confirmed by either microscopy or rapid diagnosis tests for malaria antigens before drugs were administered. The engagement of the broader community ensured high coverage of these drug-based interventions, and the directly-observed therapy improved patient safety during drug administration. CONCLUSION: A large number of radical, preventive and presumptive treatment regimens for malaria had been tried in China with reported success, but the impact of drug-based interventions has been difficult to quantify because they are just a part of an integrated malaria control strategy. The historical experiences of China suggest that intervention trials should be done by the local health facilities with community involvement, and a local decision is made according to their own trial results.
BACKGROUND: Globally, malaria is still a major public health challenge. Drug-based treatment is the primary intervention in malaria control and elimination. However, optimal use of mass or targeted treatments remains unclear. A variety of radical, preventive and presumptive treatment regimens have been administrated in China and a systematic review was conducted to evaluate effectiveness, and discuss experiences, limitations, and lessons learnt in relation to the use of these regimens. METHODS: The search for information includes both paper documents, such as books, malaria control annals and guidelines for malaria prevention and treatment, as well as three computer-based databases in Chinese (CNKI, WanFangdata and Xueshu.baidu) and two databases in English (PubMed and Google Scholar), to identify original articles and reports associated with drug administration for malaria in China. RESULTS: Starting from hyperendemicity to elimination of malaria in China, a large number of radical, preventive and presumptive treatment regimens had been tried. Those effective regimens were scaled up for malaria control and elimination programmes in China. Between 1949 and 1959, presumptive treatment with available anti-malarial drugs was given to people with enlarged spleens and those who had symptoms suggestive of malaria within the last 6 months. Between 1960 and 1999, mass drug administration (MDA) was given for preventive and radical treatment. Between 2000 and 2009, the approach was more targeted, and drugs were administed only to prevent malaria infection in those at high risk of exposure and those who needed radical treatment for suspected malaria. Presumptive therapy was only given to febrile patients. From 2010, the malaria programme changed into elimination phase, radical treatment changed to target individuals with confirmed either Plasmodium vivax or Plasmodium ovale within the last year. Preventive treatment was given to those who will travel to other endemic countries. Presumptive treatment was normally not given during this elimination phase. All cases of suspected were confirmed by either microscopy or rapid diagnosis tests for malaria antigens before drugs were administered. The engagement of the broader community ensured high coverage of these drug-based interventions, and the directly-observed therapy improved patient safety during drug administration. CONCLUSION: A large number of radical, preventive and presumptive treatment regimens for malaria had been tried in China with reported success, but the impact of drug-based interventions has been difficult to quantify because they are just a part of an integrated malaria control strategy. The historical experiences of China suggest that intervention trials should be done by the local health facilities with community involvement, and a local decision is made according to their own trial results.
Entities:
Keywords:
China; Malaria; Mass drug administration; Presumptive treatment; Prevention; Radical treatment; Treatment regimen
Authors: Michelle S Hsiang; Jimee Hwang; Amy R Tao; Yaobao Liu; Adam Bennett; George Dennis Shanks; Jun Cao; Stephen Patrick Kachur; Richard G A Feachem; Roly D Gosling; Qi Gao Journal: Malar J Date: 2013-11-01 Impact factor: 2.979
Authors: Kamala Thriemer; Benedikt Ley; Albino Bobogare; Lek Dysoley; Mohammad Shafiul Alam; Ayodhia P Pasaribu; Jetsumon Sattabongkot; Elodie Jambert; Gonzalo J Domingo; Robert Commons; Sarah Auburn; Jutta Marfurt; Angela Devine; Mohammad M Aktaruzzaman; Nayeem Sohel; Rinzin Namgay; Tobgyel Drukpa; Surender Nath Sharma; Elvieda Sarawati; Iriani Samad; Minerva Theodora; Simone Nambanya; Sonesay Ounekham; Rose Nanti Binti Mudin; Garib Da Thakur; Leo Sora Makita; Raffy Deray; Sang-Eun Lee; Leonard Boaz; Manjula N Danansuriya; Santha D Mudiyanselage; Nipon Chinanonwait; Suravadee Kitchakarn; Johnny Nausien; Esau Naket; Thang Ngo Duc; Ha Do Manh; Young S Hong; Qin Cheng; Jack S Richards; Rita Kusriastuti; Ari Satyagraha; Rintis Noviyanti; Xavier C Ding; Wasif Ali Khan; Ching Swe Phru; Zhu Guoding; Gao Qi; Akira Kaneko; Olivo Miotto; Wang Nguitragool; Wanlapa Roobsoong; Katherine Battle; Rosalind E Howes; Arantxa Roca-Feltrer; Stephan Duparc; Ipsita Pal Bhowmick; Enny Kenangalem; Jo-Anne Bibit; Alyssa Barry; David Sintasath; Rabindra Abeyasinghe; Carol H Sibley; James McCarthy; Lorenz von Seidlein; J Kevin Baird; Ric N Price Journal: Malar J Date: 2017-04-05 Impact factor: 2.979